Hot on the heels of a highly successful exit from its investment in Skyscanner, Scottish Equity Partners (SEP) are realising another hunch with the sale of Exco InTouch.
The Nottingham-based provider of patient engagement, data capture and digital health solutions for the clinical research and healthcare industry, which was backed by SEP and Albion Ventures, has been acquired by Philidelphia-based firm ERT.
Jan Rutherford, a partner at SEP and non-executive director of Exco InTouch commented: “Exco InTouch has been widely recognised as one of the fastest growing technology companies in the UK, quadrupling its turnover over the last three years and increasing its staff to over 180 skilled personnel.
“SEP has actively supported the company in driving technological innovation for both clinical trial and digital health programmes and expanding its partnerships with pharma companies in both the US and Europe. The acquisition by ERT is a great strategic fit, opening up further opportunities for progression and we wish the talented team continued success with this exciting next stage of growth.”
Dr. Andrew Elder, lead healthcare Partner at Albion Ventures added: “It has been a pleasure to work alongside SEP in backing the team that has delivered one of the most successful exits to date in the exciting and emerging UK digital health sector.”
A press release accompany the announcement said that the combined organisation “will provide the biopharmaceutical industry with the most advanced and comprehensive choice for electronic clinical outcome assessments, patient engagement and digital health supporting the entire clinical development to commercialisation spectrum – from early phase to late phase; from the simplest to the most complex – and will help clients minimise risks, run safer and more efficient studies, and get new clinical treatments to patients more quickly.”